Zhengye Biotechnology Holding Ltd
ZYBT · XNASCIK 1975641fmd_1K1VY01F5C2Q0FGZXX21HB8V6ZManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2022 to Dec 31, 2025, 6 periods
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total revenues | 260 | 212 | 186 | 116 |
| Cost of revenue | 112 | 94 | 95 | 92 |
| Gross profit | 148 | 118 | 91 | 24 |
| Research and development | 13 | 12 | 13 | 18 |
| Selling, general and administrative | 59 | 64 | 64 | 75 |
| Total operating expenses | 82 | 73 | 75 | 94 |
| Operating income | 66 | 45 | 16 | (71) |
| Interest expense | 3 | 4 | 4 | 3 |
| Interest and investment income | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (2) | (1) | (2) | (1) |
| Income before taxes | 64 | 44 | 14 | (72) |
| Income tax expense | 8 | 6 | 1 | 11 |
| Net income from continuing operations | 56 | 38 | 13 | (83) |
| Net income | 47 | 31 | 11 | (70) |